Pragmatic, multicentre, randomized, controlled clinical trial
in patients with Sepsis to evaluate the safety and efficacy of personalized PK/PD dosing versus standard Linezolid dosing
Acronym
SePkLin
Reference code
ICI21/00043
Description
Number of researchers 29
Total amount: 273.504 €
Non-UV principal researchers
Anxo Fernández Ferreiro
Start date
2022
January
End date
2025
December
Funding agencies:
Instituto de Salud Carlos III
Partners:
Complejo Hospitalario Universitario de Santiago (CHUS)
Project type
- EU - NextGenerationEU
